Literature DB >> 30300243

Mycobacterium chimaera infections following cardiac surgery in Italy: results from a National Survey Endorsed by the Italian Society of Cardiac Surgery.

Giangiuseppe Cappabianca1, Domenico Paparella2, Augusto D'Onofrio3, Luca Caprili4, Giuseppe Minniti5, Massimiliano Lanzafame6, Alessandro Parolari7, Francesco Musumeci8, Cesare Beghi1.   

Abstract

AIMS: A global outbreak of Mycobacterium chimaera infections following cardiac surgery and linked to contaminated heater-cooler units (HCUs) is currently ongoing. Neither the status of this outbreak in Italy nor the mitigation strategies adopted by adult cardiac surgery units (ACSUs) are currently known. In 2017, the Italian Society of Cardiac Surgery launched a national survey among the Italian ACSU to shed some light on this issue.
METHODS: In Italy, there are 90 ACSUs across 20 regions. From May to November 2017, these ACSUs were surveyed collecting data on patients diagnosed with MC infections, ACSU workload, HCU models in use and control measures adopted in the operatory room.
RESULTS: The response rate was 87.8%. The median number of cardiac procedures at each ACSU was 450/year [interquartile range (IQR) 350-650 procedures/year], and nationally, the number of procedures/year exceeded 40k. In Italy, seven patients with M. chimaera infections following cardiac procedures have been reported since 2015: all had aortic or valvular surgery as the first procedure; the median latency between the first operation and the infection was 2 years (IQR 2-3.25). Mortality for patients requiring redo cardiac surgery was 50%. M. chimaera infections risk was 0.4-1 patient every 1000 cardiac procedures. The most common HCU model in Italy is the 3T HCU (70.9%). The most common control measures adopted included implementing new HCU disinfection protocols, using sterile or filtrated water in the HCU and displacing HCU fans away from the patient: HCU replacement and microbiology testing were instead infrequent.
CONCLUSION: In Italy, the risk of contracting M. chimaera infections and the mortality reported are in line with other European countries, but significant heterogeneity exists on the mitigation strategies adopted to prevent further M. chimaera inoculations, suggesting the development of national guidelines.

Entities:  

Mesh:

Year:  2018        PMID: 30300243     DOI: 10.2459/JCM.0000000000000717

Source DB:  PubMed          Journal:  J Cardiovasc Med (Hagerstown)        ISSN: 1558-2027            Impact factor:   2.160


  4 in total

1.  Approach to the diagnosis and treatment of non-tuberculous mycobacterial disease.

Authors:  Kelly M Pennington; Ann Vu; Douglas Challener; Christina G Rivera; F N U Shweta; John D Zeuli; Zelalem Temesgen
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2021-05-08

2.  Disseminated Mycobacterium chimaera Following Open-Heart Surgery, the Heater-Cooler Unit Worldwide Outbreak: Case Report and Minireview.

Authors:  Emmanuel Lecorche; Gauthier Pean de Ponfilly; Faiza Mougari; Hanaa Benmansour; Elodie Poisnel; Frederic Janvier; Emmanuelle Cambau
Journal:  Front Med (Lausanne)       Date:  2020-06-16

3.  Mycobacterium chimaera infections following cardiac surgery in Treviso Hospital, Italy, from 2016 to 2019: Cases report.

Authors:  Walter O Inojosa; Mario Giobbia; Giovanna Muffato; Giuseppe Minniti; Francesco Baldasso; Antonella Carniato; Francesca Farina; Gabriella Forner; Maria C Rossi; Stefano Formentini; Roberto Rigoli; Pier G Scotton
Journal:  World J Clin Cases       Date:  2019-09-26       Impact factor: 1.337

Review 4.  Microbial Air Quality in Healthcare Facilities.

Authors:  Lucia Bonadonna; Rossella Briancesco; Anna Maria Coccia; Pierluigi Meloni; Giuseppina La Rosa; Umberto Moscato
Journal:  Int J Environ Res Public Health       Date:  2021-06-09       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.